BMY Latest Headlines

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields

at www.benzinga.com (Mon, 15-Dec 6:46 AM)

PayPal, SoundHound, Moderna, Devon, Bristol-Myers: Trending by Analysts

at www.tipranks.com (Sat, 13-Dec 4:02 AM)

Nasdaq, S&P 500 end week with losses as AI trade tumbles led by Broadcom guidance fears

at seekingalpha.com (Fri, 12-Dec 4:07 PM)

Bristol Myers Squibb upgraded at Guggenheim on 2026 pipeline catalysts

at seekingalpha.com (Fri, 12-Dec 2:52 PM)

Nasdaq slides more than 1% as Broadcom guidance concerns pressures AI trade

at seekingalpha.com (Fri, 12-Dec 1:28 PM)

Nasdaq slides 1.5% as Broadcom guidance concerns pressures AI trade

at seekingalpha.com (Fri, 12-Dec 12:20 PM)

Nasdaq slides 2% as Broadcom guidance concerns pressures AI trade

at seekingalpha.com (Fri, 12-Dec 11:22 AM)

Nasdaq slides more than 1.5% as Broadcom guidance concerns pressures AI trade

at seekingalpha.com (Fri, 12-Dec 11:04 AM)

Nasdaq slides more than 1.5% as Broadcom guidance concerns puts AI trade under pressure

at seekingalpha.com (Fri, 12-Dec 11:04 AM)

ImmunityBio, Moderna among winners of EU drug recommendations this week

at seekingalpha.com (Fri, 12-Dec 10:45 AM)

ImmunityBio, Novo, Moderna among winners of EU drug recommendations this week

at seekingalpha.com (Fri, 12-Dec 10:45 AM)

Nasdaq takes a hit as Broadcom guidance concerns puts AI trade under pressure

at seekingalpha.com (Fri, 12-Dec 10:31 AM)

Bristol Myers Squibb to Continue ADEPT-2 Phase 3 Alzheimer’s Psychosis Study After Data Committee Review

Market Chameleon (Wed, 3-Dec 7:31 AM)

Bristol Myers Squibb Plans Investor Event to Spotlight Hematology Strategy After ASH Meeting

Market Chameleon (Mon, 24-Nov 7:06 AM)

BMY Discontinues Librexia ACS Trial After Efficacy Review; Milvexian Still Central to Stroke and AF Research

Market Chameleon (Fri, 14-Nov 7:33 AM)

Bristol Myers Squibb Releases Q3 2025 Financial Results—Key Insights Ahead of Investor Call

Market Chameleon (Thu, 30-Oct 7:46 AM)

FDA Fast Track Designation for BMS-986446 Shines Spotlight on Bristol Myers Squibb’s Alzheimer's Strategy

Market Chameleon (Wed, 1-Oct 8:58 AM)